Trial Profile
Alirocumab in Patients With Acute Myocardial Infarction: A Randomized Controlled Double-Blinded Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Alirocumab (Primary)
- Indications Hypercholesterolaemia; Myocardial infarction
- Focus Therapeutic Use
- Acronyms VCU-AlirocRT
- 08 Feb 2019 Status changed from active, no longer recruiting to completed.
- 20 Aug 2018 Planned primary completion date changed from 1 Sep 2018 to 1 Aug 2018.
- 20 Aug 2018 Status changed from recruiting to active, no longer recruiting.